acc 200mg/sachet κονισ για ποσιμο διαλυμα
sandoz gmbh, kundl, austria - ΑΚΕΤΥΛΟΚΥΣΤΕΐΝΗ - ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ - 200mg/sachet - 0000616911 - acetylcysteine - 200.000000 mg - acetylcysteine
montelukast teva 4mg/sachet κοκκια
teva pharma b.v., haarlem, the netherlands - montelukast sodium - ΚΟΚΚΙΑ - 4mg/sachet - ineof01106 - montelukast sodium - 4.200000 mg - montelukast
kalydeco
vertex pharmaceuticals (ireland) limited - ivacaftor - Κυστική ίνωση - Άλλα προϊόντα του αναπνευστικού συστήματος - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 και 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 και 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.
orkambi
vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - Κυστική ίνωση - Άλλα προϊόντα του αναπνευστικού συστήματος - orkambi δισκία ενδείκνυνται για τη θεραπεία της κυστικής ίνωσης (κι) σε ασθενείς ηλικίας 6 ετών και άνω που είναι ομόζυγο για τη μετάλλαξη f508del στο γονίδιο cftr. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - Ηπατίτιδα c, Χρόνια - Αντιιικά για συστηματική χρήση - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
vitis vinifera extract yew pharma
yes pharmaceutical development services gmbh, friedrichsdorf - ΑΡΩΜΑΤΙΚΟ ΕΚΧΥΛΙΣΜΑ ΑΠΟ ΦΥΣΙΚΟ ΦΥΛΛΟ - ΚΟΚΚΙΑ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ - 360mg/sachet - ineof2548 - vine leaf dry extract - 360.000000 mg - other capillary stabilizing agents
brameston 2.5mg tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - bromocriptine mesilate - tablets - 2.5mg - bromocriptine mesilate (0022260511) 2,5mg base - bromocriptine
ceclor 250mg/5ml powder for oral suspension
phadisco ltd (0000003025) 185 yiannou kranidioti avenue, latsia, 2234 - cefaclor - powder for oral suspension - 250mg/5ml - cefaclor (0053994733) 250mg - cefaclor
ceclor 125mg/5ml powder for oral suspension
phadisco ltd (0000003025) 185 yiannou kranidioti avenue, latsia, 2234 - cefaclor - powder for oral suspension - 125mg/5ml - cefaclor (0053994733) 125mg - cefaclor
duspatalin retard 200mg prolonged release capsule, hard
viatris healthcare limited. (0000012172) damastown industrial park, mulhuddart, dublin 15, d15 xd71 - mebeverine hydrochloride - prolonged release capsule, hard - 200mg - mebeverine hydrochloride (0002753459) 200mg - mebeverine